StonvexLoading…
StonvexStonvexStonvexCore line items from CTRM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $35.57M | $1.17M | $0.00 | $0.00 |
Operating Income | $-18.42M | $21.43M | $22.01M | $73.09M |
Net Income | $19.27M | $14.62M | $38.64M | $118.56M |
EPS (Diluted) | $0.36 | $0.38 | $1.74 | $12.53 |
Total Assets | $797.36M | $797.38M | $605.04M | $633.15M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $151.78M | $87.90M | $111.38M | $142.37M |
Free Cash Flow OCF − CapEx | $9.35M | $-30.26M | $21.56M | $48.20M |
Shares Outstanding | 9.66M | 9.66M | 9.66M | 94.61M |